PRPO – Precipio Inc
Precipio, Inc.PRPO
$14.46Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $21,863,664.00
EPSttm : -2.06
Precipio, Inc.
$14.46
1.40%$0.1992Float Short %
1.19
Margin Of Safety %
-35
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
6.25
Price
14.46
Target Price
19
Analyst Recom
1
Performance Q
127.75
Relative Volume
0.16
Beta
0.92
Ticker: PRPO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | PRPO | 11.61 | N/A | N/A | 0 |
| 2025-07-07 | PRPO | 13.98 | N/A | N/A | 0 |
| 2025-07-08 | PRPO | 15.82 | N/A | N/A | 0 |
| 2025-07-09 | PRPO | 15.88 | N/A | N/A | 0 |
| 2025-07-10 | PRPO | 15.5 | N/A | N/A | 0 |
| 2025-07-11 | PRPO | 15.5 | N/A | N/A | 0 |
| 2025-07-14 | PRPO | 14.5 | N/A | N/A | 0 |
| 2025-07-15 | PRPO | 14.35 | N/A | N/A | 0 |
| 2025-07-16 | PRPO | 14.9094 | N/A | N/A | 0 |
| 2025-07-17 | PRPO | 14.345 | N/A | N/A | 0 |
| 2025-07-18 | PRPO | 14.7 | N/A | N/A | 0 |
| 2025-07-21 | PRPO | 14.17 | N/A | N/A | 0 |
| 2025-07-22 | PRPO | 14.13 | N/A | N/A | 0 |
| 2025-07-23 | PRPO | 14.4 | N/A | N/A | 0 |
| 2025-07-24 | PRPO | 14.21 | N/A | N/A | 0 |
| 2025-07-25 | PRPO | 14.7 | N/A | N/A | 0 |
| 2025-07-28 | PRPO | 14.4 | N/A | N/A | 0 |
| 2025-07-29 | PRPO | 14.45 | N/A | N/A | 0 |
| 2025-07-30 | PRPO | 14.4884 | N/A | N/A | 0 |
| 2025-07-31 | PRPO | 14.26 | N/A | N/A | 0 |
| 2025-08-01 | PRPO | 14.46 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | PRPO | 12.05 | - | - | -6.25 |
| 2025-07-07 | PRPO | 13.90 | - | - | -6.25 |
| 2025-07-08 | PRPO | 15.82 | - | - | -6.25 |
| 2025-07-09 | PRPO | 16.20 | - | - | -6.25 |
| 2025-07-10 | PRPO | 15.69 | - | - | -6.25 |
| 2025-07-11 | PRPO | 15.57 | - | - | -6.25 |
| 2025-07-14 | PRPO | 14.85 | - | - | -6.25 |
| 2025-07-15 | PRPO | 14.78 | - | - | -6.25 |
| 2025-07-16 | PRPO | 14.60 | - | - | -6.25 |
| 2025-07-17 | PRPO | 14.19 | - | - | -6.25 |
| 2025-07-18 | PRPO | 14.38 | - | - | -6.25 |
| 2025-07-21 | PRPO | 15.03 | - | - | -6.25 |
| 2025-07-22 | PRPO | 14.13 | - | - | -6.25 |
| 2025-07-23 | PRPO | 14.68 | - | - | -6.25 |
| 2025-07-24 | PRPO | 14.21 | - | - | -6.25 |
| 2025-07-25 | PRPO | 14.70 | - | - | -6.25 |
| 2025-07-28 | PRPO | 14.76 | - | - | -6.25 |
| 2025-07-29 | PRPO | 14.45 | - | - | -6.25 |
| 2025-07-30 | PRPO | 14.48 | - | - | -6.25 |
| 2025-07-31 | PRPO | 14.26 | - | - | -6.25 |
| 2025-08-01 | PRPO | 14.46 | - | - | -6.25 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | PRPO | 6.96 | 50.34 | 0.44 |
| 2025-07-07 | PRPO | 6.96 | 49.98 | 0.44 |
| 2025-07-08 | PRPO | 6.96 | 49.98 | 0.44 |
| 2025-07-09 | PRPO | 6.96 | 49.98 | 0.44 |
| 2025-07-10 | PRPO | 6.96 | 49.98 | 0.44 |
| 2025-07-11 | PRPO | 6.96 | 49.98 | 0.67 |
| 2025-07-14 | PRPO | 6.96 | 51.02 | 0.67 |
| 2025-07-15 | PRPO | 6.96 | 51.02 | 0.67 |
| 2025-07-16 | PRPO | 6.96 | 51.02 | 0.67 |
| 2025-07-17 | PRPO | 6.96 | 51.02 | 0.67 |
| 2025-07-18 | PRPO | 6.96 | 51.02 | 0.67 |
| 2025-07-21 | PRPO | 6.96 | 48.29 | 0.67 |
| 2025-07-22 | PRPO | 6.96 | 48.29 | 0.67 |
| 2025-07-23 | PRPO | 6.96 | 48.29 | 0.67 |
| 2025-07-24 | PRPO | 6.96 | 48.29 | 0.67 |
| 2025-07-25 | PRPO | 6.96 | 48.29 | 1.19 |
| 2025-07-28 | PRPO | 6.96 | 49.77 | 1.19 |
| 2025-07-29 | PRPO | 6.88 | 49.77 | 1.19 |
| 2025-07-30 | PRPO | 6.89 | 49.77 | 1.19 |
| 2025-07-31 | PRPO | 6.89 | 49.77 | 1.19 |
| 2025-08-01 | PRPO | 6.89 | 49.77 | 1.19 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.93
Avg. EPS Est. Next Quarter
Insider Transactions
6.89
Institutional Transactions
49.77
Beta
0.92
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
Fair Value
9.35
Quality Score
41
Growth Score
55
Sentiment Score
93
Actual DrawDown %
92.1
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.09
P/B
1.86
P/Free Cash Flow
31.23
EPS
-2.09
Average EPS Est. Cur. Y
-6.25
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-15.45
Relative Volume
0.16
Return on Equity vs Sector %
-50.2
Return on Equity vs Industry %
-37
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading